VRTXHealth careBiotechnology
$549.04
Close on Nov 4, 2026
$139.2B
Vertex develops medicines for serious diseases. Most of its sales come from treatments for cystic fibrosis, a genetic disease that affects the lungs.
As reported in the company's annual report (10-K).
Useful context, but not the main focus.
Drag across the chart to compare two days.Touch the chart with two fingers to compare two days.
What it is · Why it matters · How to read it in context.
Annual figures, fiscal years 2021-2025.
Financial figures come from company filings with the U.S. Securities and Exchange Commission (SEC). Latest filing used: November 3, 2026. Stock prices are end-of-day closing prices.